DJIA 16,979.13 59.54 0.35%
NASDAQ 4,526.48 -1.03 -0.02%
S&P 500 1,986.51 4.91 0.25%
market minute promo

Celgene (NASDAQ: CELG)

92.00 0.64 (0.70%)

REAL-TIME: Last trade at

Extended Hours: $92.19 $0.19 (0.21%)
Quote as of (NASDAQ)

company name or ticker

Recent Quotes

CELG $92.00 0.70%
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $91.33
Previous Close $91.36
Daily Range $91.11 - $93.35
52-Week Range $66.29 - $93.35
Market Cap $73.6B
P/E Ratio 52.81
Dividend (Yield) $0.00 (0.0%)
Volume 4,509,428
Average Daily Volume 4,350,704
Current FY EPS $3.18





Celgene (CELG) Description

A biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases. Website:

News & Commentary Rss Feed

3 Reasons Celgene Corporation's Stock Could Rise

Celgene stock has more than tripled over the past three years, but these three catalysts suggest it could just be getting started.

3 Drugs Stocks On The Rise

Biogen Strengthens MS Portfolio with Plegridy FDA Approval - Analyst Blog

3 Stocks Reiterated As A Buy: CELG, GE, C

Noteworthy ETF Outflows: IYH, AMGN, BIIB, CELG

Taking Profits From Netflix And Putting Them To Work In Celgene

Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and M

Jim Cramer Answers Twitter (TWTR) Questions on Walmart (WMT), Yelp (YELP), Kinder Morgan (KMI) and More

Epizyme Holds A Key To A Potential Blockbuster Drug For Hematological Cancers

Celgene (CELG) Hits New Lifetime High

No Reason for Penney to Exist; Party On, Biotech: Jim Cramer's Best Blogs

See More CELG News...

CELG's Top Competitors

CELG $92.00 (0.70%)
Current stock: CELG
AMGN $132.68 (-0.26%)
Current stock: AMGN
GILD $100.79 (-0.48%)
Current stock: GILD
$0.00 (0.00%)
Current stock: